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Summary: Over 100 laboratories participated in an external quality-control survey (EQCS) for T3 and T4, using the
Munich Model as conceived in this laboratory ((1-4): Marschner,!, et al. (1974), Horm. Met. Res. 6, 293-296;
Horn,K. et al. (1976), this J. 14,353-360; Marschner J. et al. (1976), this J. 14,345-351; Wood, W. G. et al.
(1980), this J. 18, 183-192) and carried out over the past 6 years. Twenty lyophilised serum samples, including
independant hidden standard curves for T3 and T4, were dispatched by post together with a detailed questionnaire
and full instructions on reconstitution of the samples. The returned data were processed as previously described
((4): Wood, W. G. et al. (1980), this J. 18,183-192) and each participant received a full analysis of his«own data
and a set of histogrammes with which he could visually check his performance against other laboratories. An
explanatory letter was sent, which explained the computer print-out, the coding of the kits and contained a con-
structive report of the participant's performance and helpful advice as to how to improve the assay if this was
necessary.
From 110 laboratories returning data for T3, 86 were fully useable, 22 partly and 2 unuseable because T3-uptake
had been performed instead of T3-radioimmunoassay (RIA). From 124 laboratories returning T4 EQCS data, 102
were fully useable and 22 partly useable. In both cases the partly useable sets of data did not contain important
items such as the count rates (or absorption values) for each serum, needed for construction and read-off of values
from curves I and II. For T3, intra-assay coefficients of variation (c. v.) of under 5% were seen in 40 cases, and a c. v.
of over 15% in 27 cases (range 15—67%). For T4,69 participants had a c. v. under 5% and only 7 laboratories had a
c. v. above 15% (range 15—41%). The vast majority of participants used commercial kits (T3 = 90, T4 = 106).
The results of this EQCS showed a considerable improvement in the five and a half year period since the last EQCS
for T3 and T4. This is reflected in the intra-assay c. v., especially in the T3-EQCS where the mean coefficient of
variation in 1974 was 152% for the three samples and in 1979 for three samples with a similar T3-content only 31%.
Furthermore, some of the kits now on the market show the "ruggedness" desired byJEkins ((5): Assay Design and
Quality Control: In Radioimmunology 1979 (Ed. Ch. A. Bizollon), Elsevier North Holland, pp. 239-255) that is,
kits which give the same results under widely differing conditions.
Ein zweiter Ringversuch filr Triiodthyronin (T$) und Thyroxin (T4) im Serum
Zusammenfassung: Über 100 Laboratorien nahmen an einem externen Ringversuch für T3 und T4 nach dem soge-
nannten ,JMünchner Modell", das hier entwickelt ((1-4): Marschner,1. et al. (1974), Horm. Met. Res. 6, 293-296;
Horn,K. et al.(1976), this J.14, 353-360; Marschner, L et al. (1976), this J. 14, 345-351; Wood, W. G. et al.
(1980), this 1:18,183—192) und in den vergangenen 6 Jahren durchgeführt wurde, teil. Zwanzig lyophilisierte
Serumproben einschließlich versteckter Standardkurven für T3 und T4 wurden mit der Post, zusammen mit einem
detaillierten Fragebogen und ausfuhrlichen Vorschriften für die Proben-Wiederherstellung, versandt. Die zurückge-
sandten Daten wurden, wie schon beschrieben ((4): Wood, W. G. et al. (1980), this J. 18,183-192), bearbeitet.
Jeder Teilnehmer erhielt eine ausfuhrliche Analyse seiner eigenen Werte und eine Folge von Histogrammen, mit
denen er seine Leistung gegenüber anderen Laboratorien überprüfen konnte. Zusätzlich wurde eine Erläuterung zu
Computerausdruck und Kit-Verschlüsselung sowie ein konstruktiver Bericht über die jeweilige Teilnehmerleistung
versandt und, falls notwendig, ein Rat zur Assay-Verbesserung beigefügt.
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Von den fur T3 erhaltenen Daten aus 110 Laboratorien waren 86 vollständig und 22 teilweise brauchbar. Zwei
waren unbrauchbar, da statt eines T3-RIA ein T3-Bindungstest durchgeführt wurde. Von den für 4 erhaltenen Daten
aus 124 Laboratorien waren 110 vollständig und 22 teilweise brauchbar.
Beim T3 sah man einen Intraassay-Variationskoeffizienten (VK) unter 5% in 40 Fällen und über 15% in 27 Fällen
(Spannbreite 15-67%). Beim T4 hatten 63 Teilnehmer einen VK unter 5% und nur 7 einen VK über 15% (Spann-
breite 15-41%). Der Großteil der. Teilnehmer benutzte kommerzielle Kits (T3 = 80, T4 = 106).
Die Ergebnisse dieses Ringversuchs für T3 und T4 zeigten seit dem letzten Mal während einer Zeitspanne für fünfein-
halb Jahren einen beträchtlichen Fortschritt. Dies wird deutlich im Intraassay-Variationskoeffizienten, besonders
beim T3-Ringversuch. Bei Proben mit T3-Konzentration im Nprmalbereich lag 1974 der Mittelwert der Variations-
koeffizienten bei 152%, hingegen betrug er 1979 bei Proben mit ähnlicher Konzentration nur 31%. Ferner zeigen
einige der Kits, die jetzt auf dem Markt sind, die „Robustheit", aieEkins ((5): Assay Design and Quality Control: In
Radioimmunology 1979 (Ed. Ch. A. Bizollon), Eisevier North Holland, pp. 239-255) forderte, d. h. die selben
Ergebnisse trotz Durchführung unter verschiedenen Bedingungen.
Introduction
In 1974 thirty members of the German Society for
Endocrinology, Thyroid Section, were invited to take
part in an EQCS for T3 and T4 in serum. The results of
the survey were published in detail in 1976 (2). The
results showed that the state of these assays was far
from ideal. Five years later, a similar study has been
organised in which over 100 participants from all types
of laboratory have taken part. The method for organising
and working out the data received has recently been
published (4). The major change in the EQCS-form is
that the samples were for the first time, in a survey
carried out from this laboratory, dispatched in a
lyophilised form. The methods used for the measure-
ment of the thyroid hormones in this EQCS included
RIA, EMIT (enzyme multiplied immunoassay technique),
ELISA (enzyme linked immunosorbent assay) and
CPBA (competitive protein binding assay) techniques.
Materials and Methods
Hidden standard curves were set up in T3- und T4-free human
serum (0-serum) kindly supplied by commercial kit producers
(Henning, Berlin; Amersham-Buchler, Braunschweig). T3, T4
and reverse T3 (rT3) were obtained from Henning, Berlin, in
which a purity of > 99.9% was given. To obtain full solution
of these compounds, they were first dissolved in dilute NaOH
before being diluted and added to the 0-serum.
Standard curves for T3 ranged from 0-11 nmol · liter'1 and for
T4 from 0-300 nmol · liter"1 each in 6 steps. Apart from the
0-standaid, different human serum samples were used for the
two standard curves. Serum pools were collected from patients
with elevated thyroxine binding globulin (TBG) levels as well
as from patients with normal and reduced levels. Elevated TBG
sera came from women under oestrogen therapy, and reduced
TBG serum from a patient with haemochromatosis treated by
regular venipunction. rT3 was added to one serum in a con-
centration which is often seen in fasted patients (6), and the
effect of ion-exchange removal of T3 and T4 from a»pool serum
from normal volunteers was tested in yet another serum. The
intra-assay c. v. was tested using a pool from normal volunteers
in three different vials.
All sera were filtered under 5 Bar Nj through an asbestos filter
to remove debris and bacteria.
Table 1 shows the composition of the 20 serum samples sent to
each participant. All sera were tested for TBG-levels, total
protein and electrophoretic mobility after treatment. The
capability of the serum to bind radioactive T4 was also checked




1 T3 and T4-free serum — zero standard for hidden
standard curve
(TBG 16 mg · liter"1, total protein 69 g · liter"1)
2 Commercial quality control serum — Gödecke
Validate-N
3 Poölserum extracted with anion-exchange resin, with
additional rT3 end concentration 15 nmol · liter"1
(for TBG and total protein see serum no. 7)
4 Poolserum -=· in normal range, for intra-assay c, v.
(TBG - 19 mg · liter"1, total protein - 69 g · liter"1)
5 Poolserum for intra-assay c. v. — see serum no. 4
6 Hidden standard curve - T3 - 5 nmol · liter"*
7 Pcolserum — see sample 3 for details, without added
rT3 (TBG - 16 mg · liter"1, total protein 60 g · liter"1)
8 Commercial quality control serum — Gödecke
Validate-A
9 Hidden standard curve - T4 300 nmol · liter"1
10 ' Hidden standard curve - T3 11 nmol · liter"1
11 Hidden standard curve - T4 120 nmol · liter"1
12 Serum with reduced TBG-content
(TBG - 9 mg · liter"1 Total protein - 66 g · liter"1)
13 Hidden standard curve - T3 - 1 nmol · liter"1
14 Hidden standard curve - T3 - 2 nmol · liter'1
15 Hidden standard curve - T4 - 60 nmol · liter"1
16 Hidden standard curve - T4 - 30 nmol · liter"1
17 Poolserum for intra-assay c. v. — see serum no. 4
18 Hidden standard curve - T3 - 0.5 nmol · liter"1
19 Poolserum from women on oestrogen therapy
(TBG - 54 mg · liter"1, total protein - 77 g · liter"1)
20 Hidden standard curve - T4 - 10 nmol · liter"1
AJ1 serum samples for the hidden standard curve have the same
TBG- and total protein content as serum no. 1.
TBG and Total Protein were not measured in serum nos. 2 and 8.
as an indirect measurement of the TBG-binding capacity.
Except in the specific cases, TBG-levels were normal, as were
serum total protein and electrophoresis.
Returned data was transferred to punched cards (4) and pro-
cessed in a computer (Siemens 40473).
Table 2 shows the list of commercial·kits used in this survey and
the code numbers allotted to them, together with the major
features.
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Tab. 2. List of Kits used in the T3- and T4-EQCS.
Code
Number






























Laboratory own method irrespective of assay method
Clinical Assays - RIA - Coated Tubes
Diagnostic Products Corporation - RIA - Double
antibody with polyethylene glycol (PEG) separation
Amersham — RIA — PEG separation
Corning - RIA - solid phase first antibody
Byk-Mallinckrodt - RIA - Ion exchange separation
Merck (Syva) - EMIT - homogeneous system
Beckman - RIA - Double antibody separation
Henning - RIA - Double antibody separation
Abbott - RIA - PEG separation
Behring - RIA - PEG separation
Becton-Dickinson - RIA - Coated Tubes
Pharmacia - RIA - Solid phase first antibody
Serono (Biodata) - RIA - PEG separation
BioRad - RIA - solid phase first antibody
Squibb Clasp - RIA - Coated Tubes
Byk-Mallinckrodt SPAC - RIA - Coated Tubes
Micromedic (Autopak) - RIA - Coated Tubes
Biomerieux - RIA - Double antibody with PEG
separation
Boehringer - RIA - Coated Tubes
Boehringer - ELISA - Coated tubes
Amersham (Thyopac) — CPBA — Column separation
Ames (Seralute) — RIA — Column separation
Henning (RIAcid) - RIA - Preincubated 1st and
2nd antibody
IMO - RIA - Coated Tubes
Henning — RIA — Charcoal separation
Union Carbide (Centria) - RIA - Double antibody
separation
The numbers in brackets for kits 30 and 33 are most probably
the same as kits 4 and 26 respectively. Kits numbered above 51
are modifications to the methods in the kits. e. g. Kit 51 is the
same as kit 1, but the user has modified the method in some way
or other.
Results
Participants -= According to Laboratory Type and Size,
together with Returned Data
Table 3 shows the returned data from participants and
whether they could be fully or only partly evaluated,
the table is split up into laboratory type and size.
the figures in the square brackets indicate the percen-
tage of all laboratories, those in the round brackets the
percentage of the group in question. The table shows
that around 80% of all participants could fill out the
questionnaires and send back their data in the required
form. This ability was seen to the same extent in both '
general and radiological laboratories. In the cases of
partly useable results, data failed, thus preventing the
construction of curves I and II, and restricting the data
returned to the participant.
Performance (Intra-assay c. v.) - According to Laboratory
Type and Size
Table 4 shows the intra-assay c. v. in terms of laboratory
type and size. The figures in square brackets represent
the percentage within each group and the round brackets
have the same meaning as in table 3 above. In the T3-
EQCS, 36% of the participants had an intra-assay c. v.
of under 5 % and 25 % an intra-assay c. v. of over 15 %.
The same data for the T4-EQCS were 56% and 6%
respectively. A difference in performance between
general laboratories performing radioimmunoassays
and those specialising in nuclear medicine was not to be
seen.
Performance — Own Methods and Commercial Kits
Table 5 shows the performance in the T3-EQCS in terms
of all participants, those using their own method, and
for the kits with 5 or more sets of returned data (please
refer to table 2 for the kit code).
As the amount of data here is enormous, two things
have been done, namely the sera have been organised
into ascending concentration order expressed by the
group mean, and the simplification of data into table 6
which shows the mean c. v. for the ranges shown.
Table 6 shows a "precision-profile" in simplified form.
Tables 7 and 8 show the same procedure for the T4-
EQCS.
Outliers in both T3- and T4-EQCS are underlined in
both tables 5 and 7 where accuracy is questionable. The
3 samples for the intra-assay t. v. (samples 4, 5 and 17)
are outlined to allow an easy comparison to be made.
Crossreaction of T3, T4 and rT3
From the results in table 5 it can be seen that for the
highest T4-standard (sample 9-300 nmol - liter"1) only
one kit (kit 4) showed a crossreaction giving a "T3"
value of 1.71 nmol · liter""1. In the normal range of T4
(samples 15 and 11-60 and 120 nmol - liter"1) cross-
reaction was not high enough to falsify results. Again
kit 4 had the highest cross-reactivity. No T3-kit showed
demonstrable crossreaction with rT3 (samples 3 and 7).
In the T4-EQCS crossreaction of T3 played no role due
to the concentration difference. The same was true for
rT3, although almost all antibodies crossreacted with
rT3 (samples 3 and 7, table 7).
Regression Data Analysis
Table 9 shows the regression data for both T3- and
T4-EQCS. In the first instance for the comparison of
data read off the participant's own standard curve using
his own method for working out the results (own
method) and the same data after standardisation using
a spline function (7) (curve I). Any deviation from the
ideal value of the regression line y = a + bx where a = 0
and b = 1, stems from a difference in the working out
J. Clin. Chem. Clin. Biochem. / Vol. 18,1980 / No. 8
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The square brackets represent the percentage of all laboratories, whereas the round brackets represent the percentage of the two
groups in question.
Tab. 4. Analysis of returned data — Intra-assay c. v. — according to laboratory size and type.















































































Small Private 2 [50] 1 [25] 1 [25] 0
Large Private 0 0 0 4 [100]
University 5 [38] 2 [15] 1 [8] 5 [38]













































The square brackets represent the percentage of each group of laboratories - these figures when read horizontally equal 100%.
The round brackets represent the percentage of the two main groups - General and Radiology, and can be used in comparing
performance directly.
method or data transformation process. The second
instance shows a comparison of standardised data from
the participant's standard curve (curve I) compared with
the values read off the hidden standard curve (curve II).
Differences occurring through methodology are seen in
cases where a differs widely from 0 and b deviates widely
from 1. In such cases, where the correlation coefficient
remains highly significant, a systematic error is indicated.
Where the value of the correlation coefficient (r) falls,
random errors come into play.
The boundaries for a, b and r in table 9 were chosen,
arbitrarily. The results seen in this table are probably
the most important in the whole survey, and demon-
strate that a good correlation exists between own
method of data handling and the spline function used
to standardise the data transformation, at least in the
majority of laboratories (Tj = 88%, T4 = 89%). In the
case of both surveys most of the participants had a
regression line slope within 10% of the expected Value
of 1.00 (T3 = 81%, T4 55 86%) which in a similar propor-
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Tab. 9. Analysis of regression data from T3- and T4-EQCS.
Regression data for the equation y = a + bx, the first term
of the two parameters is entered as x.































































































The above data exclude 18 T3- and 23 T4-EQCS participants
who returned insufficient data. The figures in brackets represent
the percentages of the useable data.
tion of the cases passed near to the origin (T3 = 86%,
T4 = 98%).
The corresponding data for the comparison between
curve I and curve II are as perhaps expected not so good.
The correlation between the two curves was similar to
that between the own curve and curve I (T3 = 95%,
T4 = 90%) although both the slope of the regression
line varied widely, with only 54% of T3 and 38% of
T4-EQCS participants lying between the limits
b = 0.9-1.1. The number of regression lines passing
through or near the origin was also fewer (T3 = 47%,
T4 = 68%).
Comparison of Binding of Tracer to the Kit -
Own Method and Hidden Standard Curve Zero Standards
Table 10 shows the comparison of the binding of the
tracer to the own-method zero standard with the binding
to the hidden standard curve zero standard. The ideal
value is 100%. The range chosen as acceptable in both
cases was between 90 and 110%. 76% of the T3-EQCS
participants and 55 % of those taking part in the T4-
EQCS lay within this range.
Comparison of Curve I and Curve Π
for Superimposibility
Table 11 shows a subjective comparison of the kit/own-
method and hidden standard curves with regard to their
Superimposibility. Superimposibility was seen in 38% of
Tab. 10. Comparison of binding of serum no. 1 with own-
method zero standard. All figures are expressed as











Data from 90 T3-Curves and 107 T4-Curves. Figures in brackets
indicate percentage of processed data.












Data from 90 T3- and 107 T4-standard curves. Figures in
brackets denote percentage of processed data.
the T3-standard curves and in 32% of the T4-standard
curves. The division into good, average and poor super-
imposibility was purely subjective, no detailed mathe-
matical analysis being performed.
Discussion
As in the previous EQCS, the majority of participants
used commercial kits, with or without modification, for
the determination of total T3 and total T4 in serum. At
the time of writing, no less than 30 kits are commercially
available for these two assays. The performance of the
kits, although not as bad as those 5 years ago (2), varies
widely as seen in the precision profiles in table 6. Al-
though many kits have standard curves in human serum,
there are still several which use either animal serum or
even buffer as the matrix for the standards. A typical
result of a potentially good kit spoilt by having standards
in buffer is the case of kit 10 in the T3-EQCS. As seen
in table 6, the precision is good, but when one looks at
table 5, the accuracy is lacking. That the kit components
and methodology are otherwise in order can be seen
from the comparison of the results read off curve I
(fig. la) and those read off the hidden standard serum
curve (curve II) as seen in figure Ib. The results, when
read off the serum standard curve are not only precise,
but accurate. Only one kit-producer (kit 2) had a product
which was precise and accurate in the regions of interest
in both T3 and T4 assays. This kit was robust and also
one of the cheapest on the market, although it used a
double-antibody method of separation of bound and
free antigen.
The EMIT assay for T4 showed precision and accuracy
comparable with some RIA methods, although it is
difficult to draw too many conclusions from such a
small number of data.
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Fig. 1. Histogrammes from the T3-EQCS showing results from Kit 10 (shaded squares).
a) read off curve I (from participant's own data worked out using spline function) It is plain to see that the buffer standards in
the kit give biased results.
b) Read off curve II, the hidden standard curve in human T3-free serum. With the exception of one result, the values obtained
for serum No. 4 fall in the main block of results, thus demonstrating that the standards in the kit are responsible for the
positive bias seen in fig. la.
The figures in the boxes are: lower left, participant number and upper right, kit number.
The performance of different types of laboratory dis-
pelled the myth that only certain types of laboratory
can measure T3 and T4. This is perhaps to be expected,
as the majority of participants use kits, where it is only
necessary to follow the recipe and work with precision.
If this survey represents a true cross-section of the
laboratories performing T3 and T4 assays in the Federal
Republic of Germany, then the general RIA laboratories
performing these tests outnumber the nuclear medicine/
radiology laboratories by about 3:1.
The regression analysis and related data (tables 9—11)
demonstrate that most laboratories can work out their
data efficiently. Those having the worst correlations
were almost inevitably those laboratories who used
either a computer or desk-top calculator to evaluate
data without a visual display of the standard curve.
The results emphasise the need for a visual check of
what the calculator is doing.
The distribution of the values for r, a and b for the
regression data for the T3-EQCS was Gaussian, whereas
those for the T4-EQCS were shewed. The latter can
probably be best explained that the T4-free serum used
in the hidden standard curve was not really T4-free, but
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contained about 10 nmol · liter"1 T4 - although this
was checked in no less than 3 systems before lyophilisa-
tion. One thing is evident from this EQCS, and that is,
all T3-kits are able to measure an elevated T3-level in
serum and thus detect a case of T3-hyperthyroidisin.
Concomitantly, most T4-kits are able to differentiate
between euthyroid and hypothyroid serum levels, al-
though only one kit is able to differentiate between no
T4-output and minimal T4-output from the thyroid
gland, an important point in deciding whether the
thyroid is absent or whether cells are still present which
are producing thyroid hormones, an important fact in
the follow-up of cases of malignant thyroid carcinoma
after total thyroidectomy.
Inspite of these findings, there is still room for improve-
ment in the design of many T3 and T4-kits and methods,
especially in their "robustness". AsEkins has so often
said, a kit must be able to perform well, that is, precisely
and accurately under all possible conditions.
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